Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb

Platelets

Volumn 15, Issue 7, 2004, Pages 419-425

  Naimushin, Ya A ^a   Mazurov, A V ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EPITOPE; FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IB; GLYCOPROTEIN IIIA; IMMUNOGLOBULIN F(AB) FRAGMENT; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CRC54; MONOCLONAL ANTIBODY CRC64; PROSTAGLANDIN E1; SEROTONIN; TIROFIBAN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADSORPTION; ARTICLE; BINDING SITE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEROTONIN RELEASE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ANTIBODIES, MONOCLONAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; TYROSINE; VON WILLEBRAND FACTOR;

EID: 8744264171     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100410001721333     Document Type: Article

References (19)

1. Ruggery Z M. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003; 1: 1335-42.
2. Berndt M C, Shen Y, Dopheide S M, Gardiner E E, Andrews R K. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb Haemost 2001; 86: 178-88.
3. De Marko L, Girolami A, Zimmerman T S, Ruggeri Z M. Von Willebrand factor interaction with the glycoprotein IIb/ IIIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J Clin Invest 1986; 77: 1272-7.
4. Harfenist E J, Packham M A, Kinlough-Rathbone R L, Cattaneo M, Mustard J F. Effect of calcium ion concentration on the ability of fibrinogen and von Willebrand factor to support the ADP-induced aggregation of human platelets. Blood 1987; 70: 827-31.
5. Goto S, Ikeda Y, Saldivar E, Ruggeri Z M. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101: 479-86.
6. Berndt M C, Du X, Booth W J. Ristocitin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1988; 27: 633-40.
7. Byzova T V, Vlasik T N, Mazurov A V. Inhibition of platelet aggregation by monoclonal antibodies to glycoprotein complex IIb-IIIa. Biull Eksp Biol Med 1994; 118: 402-5 (in Russian).
8. Mazurov A V, Pevzner D V, Khaspekova S G, Dudnik O A, Byzova T V, Vlasik T N, Bakharev V N, Piscov M Yu, Staroverov I I, Ruda M Ya. Inhibition of platelet aggregation by F(ab′)2 fragments of monoclonal antibody FRaMon (CRC64) against glycoproteins IIb-IIIa in vitro and in healthy volunteers. Ter Arkh 2001, 73: 66-73 (in Russian).
9. Mazurov A V, Khaspekova S G, Byzova T V, Tikhomirov O Yu, Berndt M C, Steiner B, Kouns W C. Stimulation of platelet glycoprotein IIb-IIIa (αIIbβ3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa. FEBS Lett 1996; 391: 84-8.
10. Naimushin YaA, Mazurov A V. Role of glycoprotein IIb-IIIa (αIIbβ3-integrin) in the stimulation of secretion from platelet granules. Biochemistry (Moscow) 2003; 68: 209-16.
11. Khaspekova S G, Vlasik T N, Byzova T V, Vinogradov D V, Berndt M C, Mazurov A V. Detection of the epitope specific for the dissociated form of glycoprotein IIIa of platelet membrane glycoprotein IIb-IIIa complex and its expression on the surface of adherent platelets. Br J Haematology 1993; 85: 332-40.
12. Mazurov A V, Vinogradov D V, Kabaeva N V, Antonova G N, Romanov YuA, Vlasik T N, Antonov A S, Smirnov V N. A monoclonal antibody, VM64, reacts with a 130 kDa glycoprotein common to platelets and endothelial cells: heterogeneity in antibody binding to human aortic endothelial cells. Thromb Haemost 1991; 66: 494-9.
13. Smirnova I V, Khaspekova S G, Ignatov V V, Mazurov A V. Interaction of wheat germ agglutinin and concanavalin A with platelets. Stimulation of platelet functional reactions and binding with membrane glycoproteins. Biochemistry (Moscow) 1998; 63: 710-18.
14. Agafonova O G, Vinogradov D V, Khaspekova S G, Lagutina N Ya, Labinskaya T A, Vasil'ev S A, Mazurov A V. The immunodiagnosis of thrombocyte membrane glycoprotein deficiencies: Glanzmann's thrombasthenia, Bernard-Soulier syndrome and GMP-140 deficiency. Biull Eksp Biol Med 1992; 114: 635-7 (in Russian).
15. Suzuki K, Sato K, Kamohara M, Kaku S, Kawasaki T, Yano S, Iizumi Y. Comparative studies of a humanized anti-glycoprotein IIb-IIIa monoclonal antibody, YM 337, and abciximab on in vitro antiplatelet effect and binding properties. Biol Pharm Bull 2002; 25: 1006-12.
16. Frelinder A L, Du X, Plow E F, Ginsberg M H. Monoclonal antibodies to ligand-induced conformers of integrin αIIbβ3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity and function. J Biol Chem 1991; 266: 17106-11.
17. Kouns W C, Wall C D, White M M, Fox C F, Jennings L K. A conformation dependent epitope of human platelet glycoprotein IIIa. J Biol Chem 1990; 265: 20594-601.
18. Mondoro T H, Wall C D, White M M, Jennings L K. Selective inhibition of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor. Blood 1996; 88: 3824-30.
19. Lages B, Weiss H J. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin- anticoagulated platelet-rich plasma and the effects of chelating agents. Thromb Haemost 1981; 45: 173-9.